Company profile · Biotech & medical
合富醫療控股股份有限公司 · 4745
Drafted and translated from cited sources, with links to the passages they are based on for your verification. Care is taken to translate its original meaning from Mandarin as closely as possible.
Cowealth Medical Holding supplies in vitro diagnostic equipment, reagents, and consumables, and provides agency services for medical devices and consumables.[1]
The company engages in the sales, trading, and maintenance of in vitro diagnostic equipment, reagents, and consumables.[2]
Its product offerings include automated clinical chemistry analyzers, 3-part and 5-part hematology analyzers, chemiluminescence immunoassay systems, blood coagulation analyzers, blood gas analyzers, and tumor treatment devices.[1]
| Latest month | Revenue | Year on year | Month on month |
|---|---|---|---|
| 2026-10 | NT$184m | +12.5% | -46.9% |
2024-11 to 2026-10, monthly revenue.
| Last 20 trading days | Net |
|---|---|
| 2026-10-12 to 2026-11-10 | −NT$1m |
Net buying (green) and selling (red) by foreign investors, NT$ at each day's close. All companies.
| Full English name | Cowealth Medical Holding Co., Ltd. |
|---|---|
| Chinese name | 合富醫療控股股份有限公司 |
| Stock code | 4745 (TPEx) |
| Industry | Biotech & medical |
| Founded | 04 Nov 2005 |
| Listed | 30 Jan 2013 |
| Paid-in capital | NT$662m |
| Chairman | 王瓊芝 |
| President | 李惇 |
| Headquarters | Suite 102, Cannon Place, North Sound Rd., George Town,P.O. Box 712, Grand Cayman, KY1-9006, Cayman Islands |
| Website | https://www.cowealthholding.com |
| Official business description | 從事體外診斷設備、試劑暨耗材之銷售買賣及維修業務 · 產品代理儀器及耗材之銷售買賣及維修業務 |
Facts from MOPS company basic information, retrieved 03 Nov 2026. The official business description is the company's own entry and can be out of date.
Generated 2026-11-11 00:39.